Childhood Abuse and Platelet Tritiated-Paroxetine Binding in Bulimia Nervosa: Implications of Borderline Personality Disorder
J Clin Psychiatry 2000;61(6):428-435
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Background: Co-occurrence of bulimia nervosa and
borderline personality disorder has been attributed to shared
factors, including childhood abuse and disturbances in central
serotonin (5-hydroxytryptamine; 5-HT) mechanisms. To explore this
notion, we conducted a controlled assessment of childhood abuse
and 5-HT function in bulimics with and without borderline
Method: Forty patients with bulimia nervosa, confirmed with
the Eating Disorders Examination interview (14 with borderline
personality disorder and 26 without), and 25 normal-eater controls were assessed for clinical symptoms (eating disturbances, mood lability, impulsivity, and dissociation) and childhood sexual and physical abuse. We also conducted tests of platelet tritiated-paroxetine binding in blood samples from 27 of the bulimics (11 with borderline personality disorder and 16 without) and 16 of the controls.
Results: Relative to normal eaters, bulimics
showed greater affective instability, overall impulsivity, and a
history of physical abuse. However, borderline bulimics alone
showed elevated motor impulsivity, dissociation, and rates of
sexual abuse. Paroxetine-binding tests indicated no differences
attributable to comorbid borderline personality disorder, instead
linking bulimia nervosa with or without borderline personality
disorder to substantially reduced 5-HT transporter density.
Conclusion: Results suggest relatively
autonomous pathologic entities: one, relevant to bulimia nervosa,
being associated with abnormal 5-HT transporter function and
affective instability, but relatively independent of childhood
sexual abuse; another, relevant to borderline personality
disorder, onto which sexual abuse, dissociative symptoms, and
behavioral impulsivity converge. We propose that abnormal 5-HT
function may, however, constitute one basis for the frequent
co-occurrence of bulimic and borderline disturbances.